Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Protagonist Therapeutics Inc., 3 years.
Protagonist Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Protagonist Therapeutics Inc. June 20, 202578.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 8, 2026 | Protagonist Therapeutics Inc. | Open-market sale | −6,000 | $100.00 | $600,000 |
| May 8, 2026 | Protagonist Therapeutics Inc. | Open-market sale | −5,130 | $100.00 | $513,000 |
| May 7, 2026 | Protagonist Therapeutics Inc. | Option exercise | +24,000 | $6.45 | $154,800 |
| May 7, 2026 | Protagonist Therapeutics Inc. | Option exercise | +12,000 | $6.98 | $83,760 |
| May 7, 2026 | Protagonist Therapeutics Inc. | Open-market sale | −36,000 | $100.14 | $3,605,040 |
| May 7, 2026 | Protagonist Therapeutics Inc. | Open-market sale | −12,000 | $100.07 | $1,200,840 |
| Jan 2, 2026 | Protagonist Therapeutics Inc. | Grant or award | +2,695 | — | — |
| Jan 2, 2026 | Gossamer Bio Inc. | Grant or award | +115,750 | — | — |
| Oct 1, 2025 | Gossamer Bio Inc. | Grant or award | +181,250 | — | — |
| Jan 2, 2025 | Protagonist Therapeutics Inc. | Grant or award | +5,130 | — | — |
| Jun 18, 2024 | Gossamer Bio Inc. | Open-market purchase | +100,000 | $0.59 | $59,000 |
| Mar 27, 2024 | Gossamer Bio Inc. | Open-market sale | −6,430 | $1.16 | $7,459 |
| Nov 13, 2023 | Gossamer Bio Inc. | Open-market purchase | +200,000 | $0.56 | $112,000 |
| Jul 24, 2023 | Gossamer Bio Inc. | Grant or award | +54,020 | $1.82 | $98,316 |
| Apr 4, 2023 | Gossamer Bio Inc. | Open-market purchase | +55,000 | $1.02 | $56,100 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.